Edgewise Therapeutics, Inc. · NASDAQ:EWTX

Paradigm Biocapital Advisors LP reported a 6.20% stake in Edgewise Therapeutics, Inc. (Schedule 13G/A)

Event Dec 31, 2025 · Filed Feb 17, 2026

Paradigm Biocapital Advisors LP reported a 6.20% stake in Edgewise Therapeutics, Inc., 6,541,210 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).

Stake
6.20%
Shares
6,541,210
Intent
Passive
What changed
Stake changed
Filed together
4 holders

The filing in full

HolderStakeShares
Paradigm BioCapital Advisors LP6.20%6,541,210
Paradigm BioCapital Advisors GP LLC6.20%6,541,210
Senai Asefaw, M.D.6.20%6,541,210
Paradigm BioCapital International Fund Ltd.5.50%5,778,924

Source

View original at SEC

Related